Professor Tim Key
Contact information
+44 (0)1865 289648
Fax +44 (0)1865 289610
Research groups
- An investigation into cancer risk factors and mechanisms: a DPhil in molecular epidemiology
- An investigation into cancer risk factors and mechanisms: a DPhil in molecular epidemiology
- Cancer Epidemiology Unit (CEU)
- Diet and risk of site-specific cancers in the Million Women Study: prospective research including 800,000 women
- Musculoskeletal health of vegetarians
- Prostate cancer epidemiology
- The molecular epidemiology of prostate cancer
Colleges
Tim Key
BVM&S, MSc, DPhil
Professor of Epidemiology & Deputy Director, CEU
- Cancer Epidemiology Unit
- MSc in Global Health Science module 9 lead: Nutritional Epidemiology
Tim Key has worked as a cancer epidemiologist at the University of Oxford since 1985. His main interests are the roles of diet and hormones in the aetiology of cancer, particularly cancers of the breast, prostate and colon, and the health status of vegetarians and vegans. He currently works mostly on the European Prospective Investigation into Cancer and Nutrition (EPIC), as the principal investigator of the Oxford cohort of 60,000 subjects, including 30,000 people who don’t eat meat. He is also chairman of the EPIC prostate cancer group, co-ordinates the Endogenous Hormones and Breast Cancer Collaborative Group, and is a member of the UK Department of Health’s Scientific Advisory Committee on Nutrition.
Recent publications
-
Methods and participant characteristics in the Cancer Risk in Vegetarians Consortium: A cross-sectional analysis across 11 prospective studies
Journal article
Dunneram Y. et al, (2024), medrxive
-
Circulating NMR Metabolites in White and British Indian Vegetarians and Non-Vegetarians in the UK Biobank
Conference paper
Tong TYN. et al, (2023), The 14th European Nutrition Conference FENS 2023
-
Plasma Proteomic Profiles of White British and British Indian Vegetarians and Non-Vegetarians in the UK Biobank
Conference paper
Tong TYN. et al, (2023), The 14th European Nutrition Conference FENS 2023
-
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Journal article
Wang A. et al, (2023), Nat Genet, 55, 2065 - 2074
-
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Journal article
Darst BF. et al, (2023), JAMA Oncol, 9, 1514 - 1524